| |
|
| |
 |
|
Peter M. Hecht, Ph.D.
Chief Executive Officer |
|
Brian M. Cali, Ph.D.
Vice President, Program Management |
|
Mark G. Currie, Ph.D.
Senior Vice President, R&D and Chief Scientific Officer |
|
James M. DeTore
Vice President, Finance |
|
Halley Gilbert, Esq.
Vice President, Legal Affairs and General Counsel |
|
Michael J. Higgins
Chief Operating Officer and Chief Financial Officer |
|
Jeffrey M. Johnston, M.D., F.A.C.P.
Vice President, Clinical Development and Chief Medical Officer |
|
G. Todd Milne, Ph.D.
Vice President, Biology |
| Todd Milne, an Ironwood founder, has provided scientific management leadership since Ironwood’s founding in 1998, and has been vice president of biology since October 2001. Previously, Milne was a fellow at Whitehead Institute for Biomedical Research. Milne’s research has earned him numerous awards and acknowledgements including fellowships from Merck and the Damon Runyon-Walter Winchell Cancer Research Fund. He earned a B.S. in molecular biophysics and biochemistry from Yale University and holds a Ph.D. in microbiology and molecular genetics from Harvard Medical School. |
|
James J. O'Mara
Vice President, Business Development |
|
John J. Talley, Ph.D.
Senior Vice President, Drug Discovery |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
